• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

HilleVax, Inc. - Common Stock (NQ:HLVX)

2.090 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about HilleVax, Inc. - Common Stock

< Previous 1 2 Next >
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
September 17, 2025
HilleVax Stockholders Received $1.95 Per Share in Cash Plus a Contingent Value Right 
From XOMA Royalty Corporation
Via GlobeNewswire
HILLEVAX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc. - HLVX
August 19, 2025
From Kahn Swick & Foti, LLC
Via GlobeNewswire
Shareholder Alert: The Ademi Firm Investigates Whether HilleVax, Inc. Is Obtaining a Fair Price for Its Public Shareholders
August 08, 2025
From Ademi & Fruchter LLP
Via Business Wire
HilleVax Reports Second Quarter 2025 Financial Results
August 06, 2025
From HilleVax, Inc.
Via GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCS, HLVX, BSGM, TTNP on Behalf of Shareholders
August 06, 2025
From Halper Sadeh LLC
Via GlobeNewswire
HILLEVAX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc. - HLVX
August 05, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq – HLVX), Steelcase Inc. (NYSE – SCS), LAVA Therapeutics N.V. (Nasdaq – LVTX), Arcadia Biosciences, Inc. (Nasdaq – RKDA)
August 04, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
HLVX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of HilleVax, Inc. Is Fair to Shareholders
August 04, 2025
From Halper Sadeh LLC
Via Business Wire
HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right
August 04, 2025
From XOMA Royalty Corporation
Via GlobeNewswire
HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
May 08, 2025
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress
March 28, 2025
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
November 07, 2024
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
August 08, 2024
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Announces Reduction in Force
July 31, 2024
From HilleVax, Inc.
Via GlobeNewswire
HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
July 15, 2024
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
July 09, 2024
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
HLVX Investors Have Opportunity to Join HilleVax, Inc. Securities Fraud Investigation with the Schall Law Firm
July 08, 2024
From The Schall Law Firm
Via Business Wire
HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants
July 08, 2024
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
May 09, 2024
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress
March 20, 2024
From HilleVax, Inc.
Via GlobeNewswire
HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference
February 05, 2024
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer
January 18, 2024
From HilleVax, Inc.
Via GlobeNewswire
HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China
January 08, 2024
Collaboration leverages HilleVax’s leading norovirus vaccine development expertise and adds a Phase 1-ready next-generation program to HilleVax’s pipeline 
From HilleVax, Inc.
Via GlobeNewswire
HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
November 09, 2023
From HilleVax, Inc.
Via GlobeNewswire
HilleVax to Present at Upcoming Investor Conferences
November 01, 2023
From HilleVax, Inc.
Via GlobeNewswire
HilleVax to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference
September 26, 2023
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
September 25, 2023
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Announces Pricing of Public Offering of Common Stock
September 19, 2023
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Announces Proposed Public Offering of Common Stock
September 19, 2023
From HilleVax, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Recent Quotes
View More
Symbol Price Change (%)
GOOG  246.19
+1.55 (0.63%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap